Skip to main content

Alembic's Aleor joint venture gets FDA approval for generic Clobex

Levy

Alembic’s joint venture Aleor Dermaceuticals has received the Food and Drug Administration’s green light for clobetasol propionate spray, 0.05%.

The product is the generic of Galderma’s Clobex spray, 0.05%.

Clobetasol propionate spray, 0.05% is indicated for the treatment of moderate to severe plaque psoriasis affecting up to 20% body surface area in patients 18 years of age or older.

Clobetasol propionate spray, 0.05%, had a market value of roughly $22 million for the 12 months ended December 2018, according to IQVIA.

X
This ad will auto-close in 10 seconds